Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Non-Current Assets: 2012-2025

Historic Non-Current Assets for Ascendis Pharma A (ASND) over the last 11 years, with Sep 2025 value amounting to $160.1 million.

  • Ascendis Pharma A's Non-Current Assets rose 21.46% to $160.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.1 million, marking a year-over-year increase of 21.46%. This contributed to the annual value of $128.4 million for FY2024, which is 2.87% down from last year.
  • Per Ascendis Pharma A's latest filing, its Non-Current Assets stood at $160.1 million for Q3 2025, which was up 4.83% from $152.8 million recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Non-Current Assets ranged from a high of $335.4 million in Q1 2021 and a low of $126.8 million during Q4 2024.
  • Over the past 3 years, Ascendis Pharma A's median Non-Current Assets value was $150.3 million (recorded in 2024), while the average stood at $147.5 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first spiked by 335.05% in 2021, then slumped by 46.86% in 2022.
  • Ascendis Pharma A's Non-Current Assets (Quarterly) stood at $319.2 million in 2021, then tumbled by 46.86% to $169.6 million in 2022, then declined by 22.07% to $132.2 million in 2023, then dropped by 4.10% to $126.8 million in 2024, then increased by 21.46% to $160.1 million in 2025.
  • Its Non-Current Assets stands at $160.1 million for Q3 2025, versus $152.8 million for Q2 2025 and $147.2 million for Q1 2025.